ABCC1 and acute myeloid leukemia: Of note, HL-60 cells have been reported to acquire resistance to several drugs used in AML chemotherapy including cytarabine, anthracyclines doxorubicin, and daunorubicin as well as arsenic trioxide via mechanisms related to modulation of P-gp, MRP1, or BCRP expression [92,93,94].